Edinburgh, Scotland will host the upcoming International Mass
Spectrometry Conference (IMSC) on 31 August to 5 September this
year. The conference organisers, the International Mass
Spectrometry Society asserts that the 'forward...
Billion dollar science and technology company Dowpharma, a business
unit of The Dow Chemical company, has announced new capabilities in
catalytic asymmetric hydroformylation (AHF) of olefins for
applications in the development and...
Akzo Nobel business unit Diosynth, which specialises in the
production of complex active biopharmaceutical ingredients for the
pharmaceutical sector, has developed a new method for manufacturing
synthetic peptides that, it claims,...
US company PPD is taking a stake in Chemokine Therapeutics, a
Canadian- and US-based biotechnology company, to continue
development of a proprietary peptide derived from a particular
chemokine that may make the peptide useful as a...
Canadian drug discovery company Phytobiotech has entered into an
agreement to supply Achillion Pharmaceuticals with purified, plant
derived small molecules (phytochemicals) from its PurePhytoLib
library. The collaboration marks a...
TUBITAK, the scientific and technical research council of Turkey,
with the support of the European Commission, is organising a Sixth
Framework Programme (FP6) information day and launch conference, to
take place from 24 to 25 April...
An expert group on intellectual property rights (IPRs) has warned
that rules governing the protection of copyrights, database rights
and patents hamper scientific endeavour and must be changed 'in the
interest of society',...
US provider of drug discovery tools Deltagen saw cutbacks in
workforce and the closure of operating units help boost revenue by
93 per cent for the fourth quarter of 2002 to $4.7 million (€4.3m),
compared to $2.5 million (€2.3m) for...
Total revenues for the four emerging sectors of protein array,
crucial antibody array, peptide biochip, protein biochip, and
solution bead/particle array were estimated at $90 million
(€83million) in 2002, writes market analyst Business...
Millipore, which specialises in providing technologies, tools and
services for the discovery, development and production of new
therapeutic drugs, has reported first-quarter 2003 sales of $187
million (€173 million), up 13 per cent...